American Association for Cancer Research
Browse

FIGURE 1 from Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer

Download (697.05 kB)
figure
posted on 2023-06-20, 14:20 authored by Simona Lombardi, Aaron R. Goldman, Hsin-Yao Tang, Andrew V. Kossenkov, Heng Liu, Wei Zhou, Meenhard Herlyn, Jianhuang Lin, Rugang Zhang

CARM1 regulates genes involved in FA metabolism. A, Expression of CARM1 and a loading control β-actin in control and CARM1 knockout (KO) A1847 cells determined by immunoblot. B, Scatter plot of KEGG pathway analysis for genes upregulated in wildtype compared with CARM1 KO A1847 cells (WT/KO >2, FDR < 0.05). Dot size represents gene number, color represents P value. P values were calculated by KEGG analysis. C, Volcano plot illustrating the protein expression detected by RPPA in wildtype or CARM1 KO A1847 cell lysates. Red dots and green dots indicate protein expression significantly upregulated in wildtype and knockout cells, respectively. SCD1, FASN, and ACC1 were highlighted in blue. P value was calculated using a two-tailed Student t test. D, Schematic of the MUFA synthesis pathway. E, mRNA expression of ACC1, FASN, and SCD1 in control and CARM1 KO A1847 cells determined by qRT-PCR analysis. P value was calculated using a two-tailed Student t test. F, Expression of SCD1, FASN, ACC1 and a loading control β-actin in control and CARM1 KO A1847 cells as determined by immunoblot. G, Expression of SCD1, FASN, ACC1 and a loading control β-actin in control and CARM1 overexpressed CAOV3 cells as determined by immunoblot. P value was calculated using a two-tailed Student t test. Data represent mean ± SEM, n = 3 biologically independent experiments.

Funding

HHS | NIH | National Cancer Institute (NCI)

DOD | USA | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP)

Cancer Prevention and Research Institute of Texas (CPRIT)

Ovarian Cancer Research Alliance (OCRA)

History

ARTICLE ABSTRACT

CARM1 reprograms fatty acid metabolism transcriptionally to support ovarian cancer growth by producing monounsaturated fatty acids, supporting SCD1 inhibition as a rational strategy for treating CARM1-expressing ovarian cancer.